These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 869479)

  • 21. [Use of an original protocol in the study of the action of vincamine on cerebral metabolism].
    Arbus L; Espagno J; Lazortes Y; Espagno MT; Tremoulet M
    Acta Neurol (Napoli); 1974 Mar; 29(2):136-42. PubMed ID: 4850070
    [No Abstract]   [Full Text] [Related]  

  • 22. Protective activity of ethyl apovincaminate on ischaemic anoxia of the brain.
    Biró K; Kárpáti E; Szporny L
    Arzneimittelforschung; 1976; 26(10a):1918-20. PubMed ID: 1037215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vincamine in cerebrovascular insufficiency. Occupational medicine approaches in cerebral diseases].
    Steinhäuser B
    Fortschr Med; 1986 Jan; 104(1-2):23-6. PubMed ID: 3949275
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interaction of vincamine on various effects of amphetamine at the central level].
    Sardi B; Pesce E; Piacenza G
    Farmaco Prat; 1978 Aug; 33(8):351-7. PubMed ID: 748060
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative study of vincamine and rutovincine (LJ 533) on the cerebral hyperemia in rats with chronic hypoxia].
    Huyen VN; Reichart E; Duval D; Moricard Y
    Sem Hop Ther; 1977; 53(7-8):363-7. PubMed ID: 594751
    [No Abstract]   [Full Text] [Related]  

  • 26. Cerebral regulation-cerebral regulators.
    Braun P
    Ther Hung; 1980; 28(3):98-104. PubMed ID: 7221974
    [No Abstract]   [Full Text] [Related]  

  • 27. [Controlled clinical study on the activity of vincamine-teprosylate in the so-called aging brain syndrome].
    Passeri M; Cucinotta D; Mancini M; Bia A; Palummeri E
    G Clin Med; 1982; 63(11-12):874-87. PubMed ID: 7182206
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes in cerebral electrogenesis caused by vincamine in the baboon, Papio papio].
    Arfel G; de Pommery J; de Pommery H; de Lavarde M
    Rev Electroencephalogr Neurophysiol Clin; 1974; 4(1):53-67. PubMed ID: 4219639
    [No Abstract]   [Full Text] [Related]  

  • 29. The cerebral hemodynamic effect of Vincamine.
    Depresseux JC
    Acta Neurol Scand Suppl; 1977; 64():408-9. PubMed ID: 268852
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacology of vincamine and its derivatives].
    Szporny L
    Actual Pharmacol (Paris); 1977; 29():87-117. PubMed ID: 868619
    [No Abstract]   [Full Text] [Related]  

  • 31. Eburnamine derivatives and the brain.
    Vas A; Gulyás B
    Med Res Rev; 2005 Nov; 25(6):737-57. PubMed ID: 16158388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the activity of vindeburnol by spectral analysis of human EEG].
    Patat A; Klein MJ
    Therapie; 1986; 41(4):305-10. PubMed ID: 3554597
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nimodipine, nifedipine and vincamine improve amnesia induced by anisodine and sodium nitrite in rats and mice].
    Qin WC; Zhang JT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Oct; 8(5):366-70. PubMed ID: 2952309
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of ethyl apovincaminate on cerebral circulation of dogs under normal conditions and in arterial hypoxia.
    Bencsáth P; Debreczeni L; Takács L
    Arzneimittelforschung; 1976; 26(10a):1920-3. PubMed ID: 1037216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial hydroxylation of (-)-eburnamonine by Mucor circinelloides and Streptomyces violens.
    Adachi T; Saito M; Sasaki J; Karasawa Y; Araki H; Hanada K; Omura S
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):611-3. PubMed ID: 8477514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Open clinical trial with (-)eburnamonine in patients suffering from cerebral ischemia].
    Musch B; Nemni R; Giusti C; Mandelli A; Canal N
    G Clin Med; 1980 Jan; 61(1):62-73. PubMed ID: 7450346
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of hypoxic brain oedema by the administration of vasopressin receptor antagonist OPC-31260.
    Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
    Prog Brain Res; 2008; 170():519-25. PubMed ID: 18655905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of vincamine on some enzymatic activities from various areas of the beagle dog cerebral cortex.
    Benzi G; Arrigoni E; Pastoris O; Marzatico F; Curti D; Piacenza G; Villa RF
    Farmaco Sci; 1981 Sep; 36(9):811-6. PubMed ID: 7297673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and electrophysiologic changes produced by (--) eburnamonine in acute and post-acute stages of head injuries].
    Facciolla D; Ruocco A; Rossi A; Serra C; Bufalino L; Cavrini P
    Riv Neurol; 1983; 53(1):15-33. PubMed ID: 6857109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
    Franzini C; Ferrante P
    Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.